Patents by Inventor Colette Porchon

Colette Porchon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6210962
    Abstract: This invention relates to oligonucleotides encoding HCV E1 peptides, labeled oligonucleotide probes, recombinant DNA molecules comprising HCV E1 nucleotides, plasmid, expression vectors and transformed hosts.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: April 3, 2001
    Assignee: Institut Pasteur
    Inventors: Christian Brechot, Dina Kremsdorf, Colette Porchon
  • Patent number: 5919454
    Abstract: This invention relates to human or murine monoclonal antibodies specific for a peptide sequence of HCV E1, fragments of said monoclonal antibodies, hybridomas producing said monoclonal antibodies, in vitro diagnostic methods for detecting HCV E1-specific antigens in a biological sample, and diagnostic kits for detecting HCV E1-specific antigens in a biological sample.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 6, 1999
    Assignee: Institut Pasteur
    Inventors: Christian Brechot, Dina Kremsdorf, Colette Porchon
  • Patent number: 5879904
    Abstract: This invention relates to oligonucleotides encoding HCV E1 peptides, labeled oligonucleotide probes, recombinant DNA molecules comprising HCV E1 nucleotides, plasmids, expression vectors, transformed hosts, analytical kits for detecting nucleotide sequences of hepatitis C virus, and process for preparing polypeptides.
    Type: Grant
    Filed: March 18, 1993
    Date of Patent: March 9, 1999
    Assignee: Institut Pasteur
    Inventors: Christian Brechot, Dina Kremsdorf, Colette Porchon
  • Patent number: 5866139
    Abstract: This invention relates to purified HCV E1 peptides, immunogenic composition comprising purified HCV E1 peptides, and a diagnostic kit for detecting HCV E1-specific antibodies. The purified HCV E1 peptide has an amino acid selected from the group consisting of SEQ ID NO:3; SEQ ID NO:5; and SEQ ID NO:7.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 2, 1999
    Assignee: Institut Pasteur
    Inventors: Christian Brechot, Dina Kremsdorf, Colette Porchon